Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-19

Clinical Trial Update: Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate semaglutide and tirzepatide for genetic aging delay in adults with obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirzepatide (tirzepatide)
  • semaglutide (semaglutide)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Adults With Simple Obesity | NA | Status: RECRUITING